GALWAY, IRELAND--February 8, 2024--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--The rocketing demand for weight loss drugs over the past couple of years has spurred a major spike in investment in manufacturing projects and takeovers, led by market-leader pharmaceutical company Novo Nordisk A/S (NYSE:NVO) (Bagsværd, Denmark).

Within this article: Details growing investment and buyouts to capitalize in rocketing success of weight-loss drugs, leading European plant projects